nifedipine has been researched along with Electrolytes in 36 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Electrolytes: Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic efficacy of long acting diltiazem 300 mg od (Tildiem LA) was compared with sustained release nifedipine 20 mg bd and bendrofluazide 5 mg od in a multicentre study with 230 patients diagnosed with mild to moderate essential hypertension, with 77, 77 and 76 randomized to the diltiazem, nifedipine SR and bendrofluazide groups respectively." | 9.07 | A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension. ( Belgrave, GP; Hosie, J; Nasar, MA; Walters, EG, 1994) |
| "The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the therapeutic safety and efficacy of the once-a-day nifedipine gastrointestinal therapeutic system (GITS) formulation in a large and diverse cohort of patients with mild-to-moderate hypertension." | 9.06 | Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| " The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the efficacy and safety of the new once-daily nifedipine gastrointestinal therapeutic system (GITS) formulation in a large cohort of mild-to-moderate hypertensive patients overall, and to identify specific effects of therapy in the presence of complicating factors such as diabetes and obesity." | 9.06 | Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| "In a double-blind, cross-over study for 6 weeks that included 28 patients with essential hypertension, WHO stage I-II, the hypotensive action of verapamil (160 mg thrice daily) was compared with nifedipine (20 mg slow release twice daily)." | 9.05 | Verapamil compared with nifedipine in the treatment of essential hypertension. ( Hals, O; Midtbø, K; van der Meer, J, 1982) |
| "Thirty patients with moderate to severe hypertension (diastolic blood pressure greater than or equal to 115 mmHg), after a run-in wash out period of 15 days, were treated with muzolimine at a dosage of 20 mg once daily, given at 1 p." | 9.05 | Muzolimine and nitrendipine in the treatment of arterial hypertension. ( de Divitiis, O; Di Somma, S; Fazio, S; Galderisi, M; Iacono, C; Petitto, M, 1985) |
| "To determine the effect of combination of edible oils on blood pressure, anthropometric parameters, lipid profile, lipid peroxidative markers, antioxidant status and electrolytes in drug (nifedipine) taking patients with hypertension." | 7.77 | Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment. ( Al-Numair, KS; Chandramohan, G; Kalaiarasi, P; Pugalendi, KV; Rao, RK; Sudhakar, B, 2011) |
| " The pressor response to norepinephrine and angiotensin II, as well as several other blood pressure modulating factors, were studied in normal subjects (n = 9) and patients with essential hypertension (n = 10) before and after 8 weeks of treatment with the long-acting dihydropyridine amlodipine." | 7.68 | Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. ( Beretta-Piccoli, C; Bühler, FR; Donati, L; Heinen, G; Kusch, F, 1992) |
| "The short term or acute intravenous administration of nifedipine has been reported to increase urine flow rate and sodium clearance but does not significantly alter the patient's serum or urine electrolytes as other vasodilators." | 7.68 | [Effects of nifedipine, in primary hypertension, on calcium metabolism and on the excretion of the main urinary electrolytes]. ( Ariano, R; Gnocchi, E; Pecchini, F; Rivetti, V, 1991) |
| "Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker." | 7.67 | Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension. ( Bravo, EL; Fouad, FM; Pedrinelli, R; Tarazi, RC; Textor, SC, 1986) |
| "The effect of nifedipine on cellular electrolytes was studied in 14 patients (10 males, 4 females, age 39-62 years) with untreated primary hypertension." | 7.67 | Effect of nifedipine on cellular electrolytes in fourteen patients with untreated primary hypertension. ( Ericsson, F, 1985) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 6.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| "The therapeutic efficacy of long acting diltiazem 300 mg od (Tildiem LA) was compared with sustained release nifedipine 20 mg bd and bendrofluazide 5 mg od in a multicentre study with 230 patients diagnosed with mild to moderate essential hypertension, with 77, 77 and 76 randomized to the diltiazem, nifedipine SR and bendrofluazide groups respectively." | 5.07 | A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension. ( Belgrave, GP; Hosie, J; Nasar, MA; Walters, EG, 1994) |
| "The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the therapeutic safety and efficacy of the once-a-day nifedipine gastrointestinal therapeutic system (GITS) formulation in a large and diverse cohort of patients with mild-to-moderate hypertension." | 5.06 | Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| " The Modern Approach to the Treatment of Hypertension (MATH) trial was conducted to determine the efficacy and safety of the new once-daily nifedipine gastrointestinal therapeutic system (GITS) formulation in a large cohort of mild-to-moderate hypertensive patients overall, and to identify specific effects of therapy in the presence of complicating factors such as diabetes and obesity." | 5.06 | Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group. ( Bravo, EL; Friedman, CP; Krakoff, LR; Tuck, ML, 1990) |
| "In a double-blind, cross-over study for 6 weeks that included 28 patients with essential hypertension, WHO stage I-II, the hypotensive action of verapamil (160 mg thrice daily) was compared with nifedipine (20 mg slow release twice daily)." | 5.05 | Verapamil compared with nifedipine in the treatment of essential hypertension. ( Hals, O; Midtbø, K; van der Meer, J, 1982) |
| "Thirty patients with moderate to severe hypertension (diastolic blood pressure greater than or equal to 115 mmHg), after a run-in wash out period of 15 days, were treated with muzolimine at a dosage of 20 mg once daily, given at 1 p." | 5.05 | Muzolimine and nitrendipine in the treatment of arterial hypertension. ( de Divitiis, O; Di Somma, S; Fazio, S; Galderisi, M; Iacono, C; Petitto, M, 1985) |
| "To determine the effect of combination of edible oils on blood pressure, anthropometric parameters, lipid profile, lipid peroxidative markers, antioxidant status and electrolytes in drug (nifedipine) taking patients with hypertension." | 3.77 | Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment. ( Al-Numair, KS; Chandramohan, G; Kalaiarasi, P; Pugalendi, KV; Rao, RK; Sudhakar, B, 2011) |
| " The pressor response to norepinephrine and angiotensin II, as well as several other blood pressure modulating factors, were studied in normal subjects (n = 9) and patients with essential hypertension (n = 10) before and after 8 weeks of treatment with the long-acting dihydropyridine amlodipine." | 3.68 | Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. ( Beretta-Piccoli, C; Bühler, FR; Donati, L; Heinen, G; Kusch, F, 1992) |
| "The short term or acute intravenous administration of nifedipine has been reported to increase urine flow rate and sodium clearance but does not significantly alter the patient's serum or urine electrolytes as other vasodilators." | 3.68 | [Effects of nifedipine, in primary hypertension, on calcium metabolism and on the excretion of the main urinary electrolytes]. ( Ariano, R; Gnocchi, E; Pecchini, F; Rivetti, V, 1991) |
| "Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker." | 3.67 | Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension. ( Bravo, EL; Fouad, FM; Pedrinelli, R; Tarazi, RC; Textor, SC, 1986) |
| "The effect of nifedipine on cellular electrolytes was studied in 14 patients (10 males, 4 females, age 39-62 years) with untreated primary hypertension." | 3.67 | Effect of nifedipine on cellular electrolytes in fourteen patients with untreated primary hypertension. ( Ericsson, F, 1985) |
| "Enalapril treatment reduced blood pressure from 94 +/- 2 to 87 +/- 3 mm Hg (P < ." | 2.68 | Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans. ( Kaasjager, KA; Koomans, HA; Rabelink, TJ, 1995) |
| "Felodipine and placebo were infused in a double-blind, crossover study in 10 healthy normotensive volunteers." | 2.66 | Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers. ( Huysmans, FT; Koene, RA; Sluiter, HE; Thien, TA; van Lier, HJ, 1985) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 2.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| " There have been reports indicating that, in the presence of toxic doses of cocaine, the CCBs could actually potentiate cocaine toxicity in rats." | 1.31 | Nifedipine potentiates the toxic effects of cocaine in mice. ( Ansah, TA; Kopsombut, P; Shockley, DC; Wade, LH, 2002) |
| "Nifedipine induced an increase in plasma renin activity in the control group, as well as in the diabetics." | 1.28 | Effect of nifedipine on renin-angiotensin-aldosterone system and renal prostaglandins in diabetic patients. ( Andonova, K; Borissova, AM; Koev, D; Tcharaktchiev, D; Zacharieva, S, 1989) |
| "Nitrendipine-treated intact rats excreted slightly more water and Na+ and less K+ than controls, but none of the differences were significant statistically." | 1.27 | Effect of nitrendipine on urine volume, osmolality, and electrolyte excretion in normal, adrenal-enucleate, and mononephrectomized rats. ( Hall, CE; Hungerford, S, 1984) |
| "Nitrendipine was also phosphaturic and calciuric but did not alter acid excretion." | 1.27 | Renal hemodynamic and tubular transport effects of nitrendipine. ( Greenberg, A; Puschett, JB; Wallia, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (58.33) | 18.7374 |
| 1990's | 12 (33.33) | 18.2507 |
| 2000's | 2 (5.56) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudhakar, B | 1 |
| Kalaiarasi, P | 1 |
| Al-Numair, KS | 1 |
| Chandramohan, G | 1 |
| Rao, RK | 1 |
| Pugalendi, KV | 1 |
| Spirou, A | 1 |
| Rizos, E | 1 |
| Liberopoulos, EN | 1 |
| Kolaitis, N | 1 |
| Achimastos, A | 1 |
| Tselepis, AD | 1 |
| Elisaf, M | 1 |
| Hall, CE | 1 |
| Hungerford, S | 1 |
| Midtbø, K | 1 |
| Hals, O | 1 |
| van der Meer, J | 1 |
| Nami, R | 1 |
| Martinelli, M | 1 |
| Lo Monaco, B | 1 |
| Pizzuti, M | 1 |
| Nardi, PL | 1 |
| D'Ascenzo, G | 1 |
| Gennari, C | 1 |
| Wambach, G | 1 |
| Breuer, G | 1 |
| Kaufmann, W | 1 |
| López, JM | 1 |
| Arteaga, E | 1 |
| Castro, D | 1 |
| Kaasjager, KA | 1 |
| Koomans, HA | 1 |
| Rabelink, TJ | 1 |
| Hosie, J | 1 |
| Nasar, MA | 1 |
| Belgrave, GP | 1 |
| Walters, EG | 1 |
| Resnick, LM | 1 |
| Gupta, RK | 1 |
| DiFabio, B | 1 |
| Barbagallo, M | 1 |
| Mann, S | 1 |
| Marion, R | 1 |
| Laragh, JH | 1 |
| Ansah, TA | 1 |
| Wade, LH | 1 |
| Kopsombut, P | 1 |
| Shockley, DC | 1 |
| Fu, C | 1 |
| Zhao, L | 1 |
| Jiang, X | 1 |
| Cuspidi, C | 1 |
| Sampieri, L | 1 |
| Leonetti, G | 1 |
| Holub, P | 1 |
| Svec, P | 1 |
| Edelsteinová, S | 1 |
| Lazarová, Z | 1 |
| Drábková, E | 1 |
| Maldonado Martín, A | 1 |
| Quesada Simón, MA | 1 |
| Gil Extremera, B | 1 |
| Arjona García, M | 1 |
| Ruiz Martínez, M | 1 |
| Rubio Luengo, MA | 1 |
| Donati, L | 1 |
| Bühler, FR | 1 |
| Beretta-Piccoli, C | 1 |
| Kusch, F | 1 |
| Heinen, G | 1 |
| Rao, VS | 1 |
| Fonteles, MC | 1 |
| Rivetti, V | 1 |
| Ariano, R | 1 |
| Gnocchi, E | 1 |
| Pecchini, F | 1 |
| Bravo, EL | 3 |
| Krakoff, LR | 2 |
| Tuck, ML | 2 |
| Friedman, CP | 2 |
| Manninen, AK | 1 |
| Tuimala, R | 1 |
| Vapaatalo, H | 1 |
| Ahmed, T | 1 |
| Abraham, WM | 1 |
| Madeddu, P | 1 |
| Oppes, M | 1 |
| Soro, A | 1 |
| Dessi'-Fulgheri, P | 1 |
| Glorioso, N | 1 |
| Bandiera, F | 1 |
| Manunta, P | 1 |
| Rubattu, S | 1 |
| Troffa, C | 1 |
| Tonolo, GC | 1 |
| Nagaoka, A | 1 |
| Shibota, M | 1 |
| Koev, D | 1 |
| Zacharieva, S | 1 |
| Tcharaktchiev, D | 1 |
| Borissova, AM | 1 |
| Andonova, K | 1 |
| Petersen, KG | 1 |
| Ortgiese, R | 1 |
| Schuler, G | 1 |
| Khalaf, N | 1 |
| Schliebs, B | 1 |
| Kerp, L | 1 |
| Sheldon, RJ | 1 |
| Malarchik, ME | 1 |
| Fox, DA | 1 |
| Burks, TF | 1 |
| Porreca, F | 1 |
| Homaidan, FR | 1 |
| Donowitz, M | 1 |
| Wicks, J | 1 |
| Cusolito, S | 1 |
| el Sabban, ME | 1 |
| Weiland, GA | 1 |
| Sharp, WG | 1 |
| Pedrinelli, R | 1 |
| Fouad, FM | 1 |
| Tarazi, RC | 1 |
| Textor, SC | 1 |
| Sluiter, HE | 1 |
| Huysmans, FT | 1 |
| Thien, TA | 1 |
| van Lier, HJ | 1 |
| Koene, RA | 1 |
| Wallia, R | 1 |
| Greenberg, A | 1 |
| Puschett, JB | 1 |
| de Divitiis, O | 1 |
| Di Somma, S | 1 |
| Petitto, M | 1 |
| Galderisi, M | 1 |
| Iacono, C | 1 |
| Fazio, S | 1 |
| Mittal, SR | 1 |
| Mathur, AK | 1 |
| Parchwani, H | 1 |
| Haebisch, EM | 1 |
| Vallada, MG | 1 |
| Alonso, CC | 1 |
| Ek, B | 1 |
| Sjölander, M | 1 |
| DiBona, GF | 1 |
| Hallbäck-Nordlander, M | 1 |
| Ljung, B | 1 |
| Ericsson, F | 1 |
1 review available for nifedipine and Electrolytes
| Article | Year |
|---|---|
Role of calcium-channel blockers in obstructive airway disease.
Topics: Acetylcholine; Animals; Asthma; Asthma, Exercise-Induced; Calcium; Calcium Channel Blockers; Diltiaz | 1985 |
12 trials available for nifedipine and Electrolytes
| Article | Year |
|---|---|
Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Antihypertensive Agents; Aryldialkylphosphatas | 2006 |
Verapamil compared with nifedipine in the treatment of essential hypertension.
Topics: Adult; Body Weight; Calcium Channel Blockers; Creatinine; Double-Blind Method; Electrocardiography; | 1982 |
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc | 1984 |
Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
Topics: Adult; Blood Pressure; Electrolytes; Enalapril; Endothelins; Female; Humans; Kidney; Male; Nifedipin | 1995 |
A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Delaye | 1994 |
Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade.
Topics: Analysis of Variance; Blood Pressure; Calcium; Electrolytes; Erythrocytes; Female; Humans; Hydrogen- | 1994 |
Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
Topics: Aged; Aging; Blood Pressure; Cohort Studies; Delayed-Action Preparations; Electrolytes; Female; Hear | 1990 |
Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group.
Topics: Aged; Blood Pressure; Diabetes Complications; Electrolytes; Endocrine Glands; Female; Heart Rate; He | 1990 |
Natriuretic effect of acute nifedipine administration is not mediated by the renal kallikrein-kinin system.
Topics: Adult; Aldosterone; Blood Pressure; Electrolytes; Heart Rate; Humans; Kallikreins; Kidney; Kinins; M | 1987 |
[Glucose tolerance and electrolyte metabolism in nifedipine and nifedipine dihydroergotoxin treated healthy subjects].
Topics: Adult; C-Peptide; Dihydroergotoxine; Electrolytes; Glucose; Glucose Tolerance Test; Heart Rate; Huma | 1989 |
Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.
Topics: Adrenocorticotropic Hormone; Adult; Antihypertensive Agents; Blood Pressure; Diuresis; Electrolytes; | 1985 |
Muzolimine and nitrendipine in the treatment of arterial hypertension.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Double-Blind M | 1985 |
23 other studies available for nifedipine and Electrolytes
| Article | Year |
|---|---|
Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment.
Topics: Antioxidants; Blood Pressure; Calcium Channel Blockers; Electrolytes; Humans; Hypertension; Lipid Pe | 2011 |
Effect of nitrendipine on urine volume, osmolality, and electrolyte excretion in normal, adrenal-enucleate, and mononephrectomized rats.
Topics: Adrenalectomy; Animals; Calcium Channel Blockers; Diuresis; Electrolytes; Female; Glomerular Filtrat | 1984 |
[Effects of calcium antagonists (verapamil and nifedipine) on blood levels of calcium and cyclic AMP in humans].
Topics: Adult; Calcium; Coronary Disease; Cyclic AMP; Electrocardiography; Electrolytes; Female; Heart; Huma | 1981 |
[Effects of nifedipine on the blood concentration and urinary excretion of electrolytes and hormones in normal subjects].
Topics: Adult; Calcium; Calcium Channel Blockers; Electrolytes; Hormones; Humans; Male; Nifedipine; Osmolar | 1982 |
Nifedipine potentiates the toxic effects of cocaine in mice.
Topics: Animals; Calcium Channel Blockers; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, | 2002 |
[Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix].
Topics: Chlorpheniramine; Delayed-Action Preparations; Electrolytes; Indomethacin; Microspheres; Nifedipine; | 1998 |
[Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients].
Topics: Adult; Aged; Aldosterone; Blood Pressure; Catecholamines; Creatinine; Electrolytes; Female; Heart Ra | 1979 |
[The effect of verapamil and nifedipine on acid-base and electrolyte disorders induced by cholesterol in rabbits].
Topics: Acid-Base Equilibrium; Animals; Cholesterol, Dietary; Electrolytes; Male; Nifedipine; Rabbits; Verap | 1992 |
Metabolic and antihypertensive effects of nifedipine in hypertensive patients.
Topics: Adult; Blood Pressure; Body Mass Index; Electrolytes; Female; Heart Rate; Humans; Hypertension; Male | 1992 |
Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II.
Topics: Adult; Amlodipine; Angiotensin II; Antihypertensive Agents; Blood Pressure; Body Weight; Dose-Respon | 1992 |
Effects of nifedipine on renal responses to several diuretic agents in rats.
Topics: Animals; Blood Pressure; Diuresis; Diuretics; Electrolytes; Female; Kidney; Nifedipine; Rats; Rats, | 1991 |
[Effects of nifedipine, in primary hypertension, on calcium metabolism and on the excretion of the main urinary electrolytes].
Topics: Calcium; Electrolytes; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine | 1991 |
Blood pressure, plasma renin activity and calcium metabolism in hypertensive pregnancy: the effect of nifedipine.
Topics: Adult; Blood Pressure; Calcium; Electrolytes; Female; Humans; Hypertension; Nifedipine; Pregnancy; P | 1990 |
Natriuretic action of manidipine hydrochloride, a new calcium channel blocker, in spontaneously hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Electrolytes; Male; Natriuresis; Nicardipine; N | 1989 |
Effect of nifedipine on renin-angiotensin-aldosterone system and renal prostaglandins in diabetic patients.
Topics: Adult; Blood Pressure; Diabetes Mellitus, Type 1; Electrolytes; Female; Humans; Kidney; Male; Middle | 1989 |
Pharmacological characterization of neural mechanisms regulating mucosal ion transport in mouse jejunum.
Topics: Action Potentials; Animals; Atropine; Biological Transport; Carbachol; Dimethylphenylpiperazinium Io | 1989 |
Ca2+ channel blockers interact with alpha 2-adrenergic receptors in rabbit ileum.
Topics: Animals; Calcium Channel Blockers; Clonidine; Diltiazem; Egtazic Acid; Electrolytes; Ileum; In Vitro | 1988 |
Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension.
Topics: Adult; Aged; Aldosterone; Blood Volume; Body Fluids; Calcium Channel Blockers; Catecholamines; Elect | 1986 |
Renal hemodynamic and tubular transport effects of nitrendipine.
Topics: Administration, Oral; Diuresis; Electrolytes; Glomerular Filtration Rate; Humans; Infusions, Parente | 1985 |
Renal effects of calcium channel blockers in vivo.
Topics: Animals; Diltiazem; Diuresis; Electrolytes; Glomerular Filtration Rate; Nifedipine; Rabbits; Verapam | 1988 |
[In vitro effect of nifedipine on cardiovascular functions; in vitro and in situ effects on the cation profile of the aorta, myocardium and skeletal muscle of frogs].
Topics: Animals; Aorta; Electrolytes; Female; Heart; Heart Rate; Male; Muscles; Myocardial Contraction; Myoc | 1987 |
Effect of felodipine on renal hemodynamics and excretion in the dog.
Topics: Animals; Antihypertensive Agents; Dogs; Electrolytes; Felodipine; Glomerular Filtration Rate; Hemody | 1985 |
Effect of nifedipine on cellular electrolytes in fourteen patients with untreated primary hypertension.
Topics: Adult; Blood Pressure; Calcium; Electrolytes; Erythrocytes; Female; Humans; Hypertension; Male; Midd | 1985 |